Ignite Creation Date:
2024-05-06 @ 7:48 PM
Last Modification Date:
2024-10-26 @ 3:14 PM
Study NCT ID:
NCT06140641
Status:
NOT_YET_RECRUITING
Last Update Posted:
2023-11-20
First Post:
2023-09-07
Brief Title:
Effects of the Bifidobacterium Longum BL21 on BMI Metabolic Indicators and Gut Microbiota in OverweightObese Adults
Sponsor:
Qilu Hospital of Shandong University
Organization:
Qilu Hospital of Shandong University
Study Overview
Official Title:
Effects of Supplementing the Bifidobacterium Longum BL21 on BMI Metabolic Indicators and Gut Microbiota in OverweightObese Adults a Randomized Double-blind Placebo-controlled Trial
Status:
NOT_YET_RECRUITING
Status Verified Date:
2023-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The goal of this study is to investigate the effects of Bifidobacterium longum subspecies BL21 on BMI metabolic indicators and changes in gut microenvironment microbiota in overweightobese adults
The blood urine and feces samples of the subjects need to be collected at 04 and 8 week and promptly tested in the laboratory During the intervention period all groups of subjects were required to take the corresponding products daily and record adverse reactions
The blood urine and feces samples of the subjects need to be collected at 04 and 8 week and promptly tested in the laboratory During the intervention period all groups of subjects were required to take the corresponding products daily and record adverse reactions
Detailed Description:
The goal of this study is to investigate the effects of Bifidobacterium longum subspecies BL21 on BMI metabolic indicators and changes in gut microenvironment microbiota in overweightobese adults Randomized grouping was used to provide probiotic BL21 or placebo intervention The total duration of the study is 8 weeks including 8 weeks 1-8 weeks of intervention expectations The subjects were followed up at weeks 2 and 6 and sampled at weeks 0 4 and 8 After the intervention during the follow-up period blood urine and feces samples of the subjects need to be collected and promptly tested in the laboratory During the intervention period all groups of subjects were required to take the corresponding products daily and record adverse reactions
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None